PerpEquities

Equity

Abivax S.A. (ABVX) perpetual futures

Abivax S.A. is a French pharmaceutical firm discovering and optimizing therapeutic drugs for inflammatory, infectious, and oncological diseases.

-1.0%NASDAQ closed
Open in terminal

Price chart

Interactive TradingView chart

TradingView symbol NASDAQ:ABVX

Loads TradingView's third-party widget (about 1 MB) on demand.

Auto: underlying reference priceOpen in TradingView

Trading data

Perpetual market activity

0/1 live markets
Venues
1
Live markets
0/1
24h volume
-
Open interest
-
Best liquidity
-
Tightest spread
-
Highest volume
-
Settlement mix
USDT · 1/1
Perp/spot vol.
-
OI / float
-
Spot performance
1D-1.01%
5D+1.49%
1M-25.70%
6M-30.12%
YTD-34.63%
1Y-7.82%

Venue matrix

1 markets

Some venue links are sponsored. We may receive a commission, and eligible users may occasionally receive trading-fee discounts, at no additional cost to you.

Trade
BingXTradeABVX-USDTPlanned------USDT-
Best venues for this underlying

Best liquidity

-
No live data-

Tightest spread

-
No live data-

Highest volume

-
No live data-

Company data

Company fundamentals

Updated 1h ago
Market cap
$6.5B
Updated 1h ago
Revenue
$0
Trailing 12 months
Revenue growth
-
Next fiscal year
Profit margin
+17,488.9%
P/E
-16.7
Peer P/E 3.7
Free cash flow
-$138.2M
Trailing 12 months
More metrics
Net income
-$453.9M
Trailing 12 months
P/S
-
Peer P/E
3.7
Similar listed perps
Revenue estimate
$4.3M
Next fiscal year
Earnings
2026-12-21
Revenue est. $794.4K · Updated 1h ago
Dividend
-

Fundamental detail

Annual + quarterly
Latest revenue$0
Net margin0.0%
Free cash flow-$174.6M
Net debt-$527.2M
2020$70.6K
2021$0
2022$0
2023$0
2024$0
2025$0
PeriodRevenueGrowthNet incomeFCF
2020$70.6K+3,050%-$42.1M-$34.4M
2021$0-100%-$47.6M-$50.5M
2022$0--$68M-$60.8M
2023$0--$165.5M-$112.3M
2024$0--$197.4M-$173.3M
2025$0--$376.5M-$174.6M
PeriodGross marginOperating marginNet marginROEROA
2020-53,623.8%-60,330.2%-59,604.8%-209.8%-52.7%
20210.0%0.0%0.0%-163.7%-38.9%
20220.0%0.0%0.0%-844.9%-80.4%
20230.0%0.0%0.0%-75.4%-45.2%
20240.0%0.0%0.0%-434.3%-85.9%
20250.0%0.0%0.0%-73.9%-57.5%
PeriodCashDebtNet debtCurrent ratio
2020$32.8M$38.1M$5.3M1.94
2021$68M$57.9M-$10.1M2.33
2022$30.2M$43.9M$13.7M0.70
2023$282.2M$65M-$217.2M3.25
2024$161.6M$109.1M-$52.5M1.84
2025$578.6M$51.4M-$527.2M8.75
PeriodMarket capEnterprise valueP/SP/E
2020$108.9M$114.1M1,542.3-2.6
2021$126.4M$116.3M0.0-2.7
2022$165.8M$179.5M0.0-2.4
2023$467M$249.8M0.0-2.8
2024$499.3M$446.8M0.0-2.5
2025$8.9B$8.4B0.0-24.7
Q4 2022$2.5M
Q2 2023$2.5M
Q4 2023$2.6M
Q2 2024$0
Q4 2024$0
Q2 2025$0
Q4 2025$0
Q2 2026$0
PeriodRevenueGrowthNet incomeFCF
Q4 2022$2.5M--$45.1M-$49M
Q2 2023$2.5M+1%-$58.2M-$32.5M
Q4 2023$2.6M+3%-$107.3M-$79.9M
Q2 2024$0-100%-$43.4M-$56.7M
Q4 2024$0-100%-$58.7M-$37.3M
Q2 2025$0--$54.2M-$37.4M
Q4 2025$0--$322.3M-$79.8M
Q2 2026$0--$131.6M-$58.4M
PeriodGross marginOperating marginNet marginROEROA
Q4 2022+100.0%-1,726.1%-1,792.4%-560.5%-53.3%
Q2 2023+100.0%-1,758.7%-2,311.1%-64.5%-30.4%
Q4 2023+100.0%-3,975.2%-4,118.1%-48.9%-29.3%
Q2 20240.0%0.0%0.0%-30.7%-13.6%
Q4 20240.0%0.0%0.0%-129.0%-25.5%
Q2 20250.0%0.0%0.0%+100.3%-40.5%
Q4 20250.0%0.0%0.0%-63.2%-44.1%
Q2 20260.0%0.0%0.0%-32.1%-25.4%
PeriodCashDebtNet debtCurrent ratio
Q4 2022$30.2M$43.9M$13.7M0.70
Q2 2023$128.1M$38.9M-$89.3M2.82
Q4 2023$282.2M$65M-$217.2M3.25
Q2 2024$249.1M$127M-$122.1M3.04
Q4 2024$161.6M$109.1M-$52.5M1.84
Q2 2025$68.3M$94.7M$26.5M0.77
Q4 2025$578.6M$51.4M-$527.2M7.86
Q2 2026$434.7M$1.4M-$433.3M5.97
PeriodMarket capEnterprise valueP/SP/E
Q4 2022$193.7M$207.3M76.9-1.1
Q2 2023$306M$216.7M121.5-1.3
Q4 2023$523.7M$306.5M201.0-1.2
Q2 2024$890.6M$768.6M0.0-4.9
Q4 2024$500.3M$447.8M0.0-1.2
Q2 2025$461.1M$487.6M0.0-1.0
Q4 2025$8.9B$8.4B0.0-13.7
Q2 2026$10.4B$10B0.0-19.8

Refreshed 1h ago

Charts: revenue, profit, cash flow & valuation
Revenue$0Q2 2026
$651.4K$1.3M$2M$2.6MQ4 2020: $0Q2 2021: $0Q4 2021: $0Q2 2022: $2.5MQ4 2022: $2.5MQ2 2023: $2.5MQ4 2023: $2.6MQ2 2024: $0Q4 2024: $0Q2 2025: $0Q4 2025: $0Q2 2026: $0Q4 2020Q2 2026
Net income-$131.6MQ2 2026
-$241.7M-$161.1M-$80.6MQ4 2020: -$24.8MQ2 2021: -$18.5MQ4 2021: -$27.8MQ2 2022: -$33.1MQ4 2022: -$45.1MQ2 2023: -$58.2MQ4 2023: -$107.3MQ2 2024: -$43.4MQ4 2024: -$58.7MQ2 2025: -$54.2MQ4 2025: -$322.3MQ2 2026: -$131.6MQ4 2020Q2 2026
EBITDA-$137.1MQ2 2026
-$215.5M-$143.7M-$71.8MQ4 2020: -$26.2MQ2 2021: -$29.7MQ4 2021: -$28.1MQ2 2022: -$16.8MQ4 2022: -$40.5MQ2 2023: -$43.9MQ4 2023: -$103.2MQ2 2024: -$38.7MQ4 2024: -$53.3MQ2 2025: -$50MQ4 2025: -$287.4MQ2 2026: -$137.1MQ4 2020Q2 2026
Free cash flow-$58.4MQ2 2026
-$59.9M-$39.9M-$20MQ4 2020: -$24.7MQ2 2021: -$26.8MQ4 2021: -$26.2MQ2 2022: -$28.9MQ4 2022: -$49MQ2 2023: -$32.5MQ4 2023: -$79.9MQ2 2024: -$56.7MQ4 2024: -$37.3MQ2 2025: -$37.4MQ4 2025: -$79.8MQ2 2026: -$58.4MQ4 2020Q2 2026
EPS-$1.65Q2 2026
-$1.76-$1.18-$0.59Q4 2020: -$1.74Q2 2021: -$1.27Q4 2021: -$1.66Q2 2022: -$1.97Q4 2022: -$2.03Q2 2023: -$1.62Q4 2023: -$2.22Q2 2024: -$0.73Q4 2024: -$1.68Q2 2025: -$1.78Q4 2025: -$2.35Q2 2026: -$1.65Q4 2020Q2 2026
Cash / Debt$434.7MQ2 2026
$144.6M$289.3M$433.9M$578.6MQ4 2020 · Cash: $32.8MQ4 2020 · Debt: $38.1MQ2 2021 · Cash: $4.9MQ2 2021 · Debt: $35.6MQ4 2021 · Cash: $68MQ4 2021 · Debt: $57.9MQ2 2022 · Cash: $13MQ2 2022 · Debt: $54.7MQ4 2022 · Cash: $30.2MQ4 2022 · Debt: $43.9MQ2 2023 · Cash: $128.1MQ2 2023 · Debt: $38.9MQ4 2023 · Cash: $282.2MQ4 2023 · Debt: $65MQ2 2024 · Cash: $249.1MQ2 2024 · Debt: $127MQ4 2024 · Cash: $161.6MQ4 2024 · Debt: $109.1MQ2 2025 · Cash: $68.3MQ2 2025 · Debt: $94.7MQ4 2025 · Cash: $578.6MQ4 2025 · Debt: $51.4MQ2 2026 · Cash: $434.7MQ2 2026 · Debt: $1.4MQ4 2020Q2 2026
CashDebt
Profitability0.0%Q2 2026
-3,063.6%-2,009.0%-954.5%+100.0%Q4 2020 · Gross margin: 0.0%Q2 2021 · Gross margin: 0.0%Q4 2021 · Gross margin: 0.0%Q2 2022 · Gross margin: +100.0%Q4 2022 · Gross margin: +100.0%Q2 2023 · Gross margin: +100.0%Q4 2023 · Gross margin: +100.0%Q2 2024 · Gross margin: 0.0%Q4 2024 · Gross margin: 0.0%Q2 2025 · Gross margin: 0.0%Q4 2025 · Gross margin: 0.0%Q2 2026 · Gross margin: 0.0%Q4 2020 · Operating margin: 0.0%Q2 2021 · Operating margin: 0.0%Q4 2021 · Operating margin: 0.0%Q2 2022 · Operating margin: -836.0%Q4 2022 · Operating margin: -1,726.1%Q2 2023 · Operating margin: -1,758.7%Q4 2023 · Operating margin: -3,975.2%Q2 2024 · Operating margin: 0.0%Q4 2024 · Operating margin: 0.0%Q2 2025 · Operating margin: 0.0%Q4 2025 · Operating margin: 0.0%Q2 2026 · Operating margin: 0.0%Q4 2020 · Net margin: 0.0%Q2 2021 · Net margin: 0.0%Q4 2021 · Net margin: 0.0%Q2 2022 · Net margin: -1,326.4%Q4 2022 · Net margin: -1,792.4%Q2 2023 · Net margin: -2,311.1%Q4 2023 · Net margin: -4,118.1%Q2 2024 · Net margin: 0.0%Q4 2024 · Net margin: 0.0%Q2 2025 · Net margin: 0.0%Q4 2025 · Net margin: 0.0%Q2 2026 · Net margin: 0.0%Q4 2020Q2 2026
Gross marginOperating marginNet margin
Revenue growth-100.0%Q4 2024
-74.1%-48.3%-22.4%+3.5%Q2 2023: +0.9%Q4 2023: +3.5%Q2 2024: -100.0%Q4 2024: -100.0%Q4 2020Q2 2026
Shares outstanding79.6MQ2 2026
19.9M39.8M59.7M79.6MQ4 2020: 14.3MQ2 2021: 14.7MQ4 2021: 16.8MQ2 2022: 16.8MQ4 2022: 22.3MQ2 2023: 35.9MQ4 2023: 48.3MQ2 2024: 62.9MQ4 2024: 63.2MQ2 2025: 63.4MQ4 2025: 69.5MQ2 2026: 79.6MQ4 2020Q2 2026
Valuation-19.8Q2 2026
35.490.6145.8201.0Q4 2020 · P/E: -1.1Q2 2021 · P/E: -1.5Q4 2021 · P/E: -1.2Q2 2022 · P/E: -1.1Q4 2022 · P/E: -1.1Q2 2023 · P/E: -1.3Q4 2023 · P/E: -1.2Q2 2024 · P/E: -4.9Q4 2024 · P/E: -1.2Q2 2025 · P/E: -1.0Q4 2025 · P/E: -13.7Q2 2026 · P/E: -19.8Q4 2020 · P/S: 0.0Q2 2021 · P/S: 0.0Q4 2021 · P/S: 0.0Q2 2022 · P/S: 59.6Q4 2022 · P/S: 76.9Q2 2023 · P/S: 121.5Q4 2023 · P/S: 201.0Q2 2024 · P/S: 0.0Q4 2024 · P/S: 0.0Q2 2025 · P/S: 0.0Q4 2025 · P/S: 0.0Q2 2026 · P/S: 0.0Q4 2020Q2 2026
P/EP/S
Revenue$02025
$17.6K$35.3K$52.9K$70.6K2018: $20.2K2019: $2.2K2020: $70.6K2021: $02022: $02023: $02024: $02025: $020182025
Net income-$376.5M2025
-$282.4M-$188.3M-$94.1M2018: -$17.7M2019: -$34.3M2020: -$42.1M2021: -$47.6M2022: -$68M2023: -$165.5M2024: -$197.4M2025: -$376.5M20182025
EBITDA-$336.9M2025
-$252.7M-$168.4M-$84.2M2018: -$21.5M2019: -$37.2M2020: -$42.6M2021: -$43.2M2022: -$59.7M2023: -$149.2M2024: -$182.3M2025: -$336.9M20182025
Free cash flow-$174.6M2025
-$130.9M-$87.3M-$43.6M2018: -$17.2M2019: -$31.8M2020: -$34.4M2021: -$50.5M2022: -$60.8M2023: -$112.3M2024: -$173.3M2025: -$174.6M20182025
EPS-$5.212025
-$3.91-$2.6-$1.32018: -$1.742019: -$2.812020: -$2.942021: -$3.082022: -$3.562023: -$3.842024: -$3.142025: -$5.2120182025
Cash / Debt$578.6M2025
$144.6M$289.3M$433.9M$578.6M2018 · Cash: $9M2018 · Debt: $12.2M2019 · Cash: $10.9M2019 · Debt: $23.2M2020 · Cash: $32.8M2020 · Debt: $38.1M2021 · Cash: $68M2021 · Debt: $57.9M2022 · Cash: $30.2M2022 · Debt: $43.9M2023 · Cash: $282.2M2023 · Debt: $65M2024 · Cash: $161.6M2024 · Debt: $109.1M2025 · Cash: $578.6M2025 · Debt: $51.4M20182025
CashDebt
Profitability0.0%2025
-1,248,600.0%-832,400.0%-416,200.0%2018 · Gross margin: -85,327.8%2019 · Gross margin: -1,409,300.0%2020 · Gross margin: -53,623.8%2021 · Gross margin: 0.0%2022 · Gross margin: 0.0%2023 · Gross margin: 0.0%2024 · Gross margin: 0.0%2025 · Gross margin: 0.0%2018 · Operating margin: -106,155.6%2019 · Operating margin: -1,664,800.0%2020 · Operating margin: -60,330.2%2021 · Operating margin: 0.0%2022 · Operating margin: 0.0%2023 · Operating margin: 0.0%2024 · Operating margin: 0.0%2025 · Operating margin: 0.0%2018 · Net margin: -87,905.6%2019 · Net margin: -1,531,700.0%2020 · Net margin: -59,604.8%2021 · Net margin: 0.0%2022 · Net margin: 0.0%2023 · Net margin: 0.0%2024 · Net margin: 0.0%2025 · Net margin: 0.0%20182025
Gross marginOperating marginNet margin
Revenue growth-100.0%2021
+687.5%+1,475.0%+2,262.5%+3,050.0%2019: -88.9%2020: +3,050.0%2021: -100.0%20182025
Shares outstanding69.5M2025
17.4M34.8M52.1M69.5M2018: 10.2M2019: 12.2M2020: 14.3M2021: 15.5M2022: 19.1M2023: 43.1M2024: 63M2025: 69.5M20182025
Valuation-24.72025
11,250.622,525.933,801.345,076.62018 · P/E: -4.62019 · P/E: -2.92020 · P/E: -2.62021 · P/E: -2.72022 · P/E: -2.42023 · P/E: -2.82024 · P/E: -2.52025 · P/E: -24.72018 · P/S: 4,091.32019 · P/S: 45,076.62020 · P/S: 1,542.32021 · P/S: 0.02022 · P/S: 0.02023 · P/S: 0.02024 · P/S: 0.02025 · P/S: 0.020182025
P/EP/S

Next catalyst

Catalysts

Earnings
2026-12-21
Revenue est. $794.4K · Updated 1h ago

No unusual perp activity right now.

Research data

Analysts, filings and peer context

Estimates

6
DateEPS estimateRevenue estimateGrowthAnalysts
FY 2026-3.72$4.3M-4
FY 2027-3.68$52.3M-4
FY 2028-1.43$377.3M-3
FY 20292.92$955.6M-1
FY 20307.74$1.6B-1
Q4 2026-1.26$661.8K-3

Company events

6
2026-12-21EarningsActual - / Estimate -1.27-
2026-09-21EarningsActual -1.71 / Estimate -1.03Miss
2026-05-22EarningsActual -0.71 / Estimate -1.07Beat
2026-03-23EarningsActual -1.19 / Estimate -1.7Beat
2025-12-15EarningsActual -2.47 / Estimate -0.79Miss
2025-09-08EarningsActual -0.86 / Estimate -0.9Beat

Peer comparison

Similar listed perps
NameMarket capP/SP/EProfit marginVenues
IOVA$6.5B20.1-20.0-89.1%1RIOT$6.4B9.5-4.6-196.3%7ANF$6.3B1.212.0+10.0%1YONGDING$6.7B7.0105.0+6.6%1KOD$6.2B--23.80.0%3CAVA$6.2B4.593.7+4.8%1GLXY$6.7B0.1-48.1-0.2%3BLUEFOCUS$6.7B0.6118.5+0.5%1

Analyst track record

How the analysts covering ABVX have done: ratings, price-target accuracy and the measured reaction after their calls.

12 months3 years
Ratings73154
Analysts1317
Buy / hold / sell66 / 5 / 2141 / 11 / 2
Upgrades / downgrades / initiations2 / 1 / 63 / 1 / 18
Price targets hit / missed0 / 69 (0%)62 / 85 (42%)
Avg. return after a rating (TipRanks)-41.0%+62.0%
Best / worst call-2.1% / -52.9%+634.6% / -52.9%

After buy calls on this stock: median 21-day move +0.4% vs S&P 500 -1.3% (n = 132)

Most accurate on this stock

Share of an analyst's price targets on this stock that the price reached within 12 months (our measurement over the last 3 years, at least 8 targets). It describes past calls, not the odds of the current one.

  1. Jason ButlerCitizens JMP100% hit rate on this stock · 12 targets measuredBuytarget $187Jun 2, 2026
  2. Sam SlutskyLifeSci Capital80% hit rate on this stock · 20 targets measuredBuytarget $168Sep 22, 2026
  3. Julian HarrisonBTIG78% hit rate on this stock · 9 targets measuredBuytarget $175Oct 1, 2026

Latest ratings

DateAnalystCallTarget
Oct 1, 2026Julian HarrisonBTIGBuyReiterated$175
Sep 28, 2026Julian HarrisonBTIGBuyReiterated$175article ↗
Sep 28, 2026Judah FrommerMorgan StanleyBuyMaintained$180article ↗
Sep 22, 2026Julian HarrisonBTIGBuyMaintained$175article ↗
Sep 22, 2026Judah FrommerMorgan StanleyBuyReiterated$180article ↗

TipRanks data via FMP · computed Oct 12, 2026 · 73 ratings

Embed this asset

ABVX perpetuals · perpequities.comABVX perpetuals · perpequities.com
<a href="https://perpequities.com/stocks/abvx-perp"><img src="https://perpequities.com/badge/abvx-perp.svg" width="240" height="64" alt="ABVX perpetuals · perpequities.com" loading="lazy"></a>

Raw data: JSON · CSV · API

Next step

Stay on top of ABVX perps

Signals with a track record

Analysts who hit 70%+ of their targets on the perps we track, congress buys over $500k, 13F positions over $5M, funding spreads that have paid for days. Every post shows the evidence. Free, no sign-up.

Join on Telegram

Weekly digest by email

The listings, funding and moves that matter for ABVX — one email every Sunday.

Watchlist and alerts

Price and funding alerts for ABVX, via push or Telegram.

Set an alert

Follow the live feed

Daily movers, new listings and funding extremes as they happen.

Follow on X